Mosaic Financial Statements From 2010 to 2024
| CPMV Stock | USD 0.61 0.39 39.00% |
Check Mosaic Immunoengineerin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mosaic Immunoengineerin's main balance sheet or income statement drivers, such as , as well as many indicators such as . Mosaic financial statements analysis is a perfect complement when working with Mosaic Immunoengineerin Valuation or Volatility modules.
Mosaic |
Mosaic Immunoengineering OTC Stock Shares Owned By Insiders Analysis
Mosaic Immunoengineerin's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Mosaic Immunoengineerin Shares Owned By Insiders | 88.73 % |
Most of Mosaic Immunoengineerin's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mosaic Immunoengineering is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 88% of Mosaic Immunoengineering are shares owned by insiders. This is much higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Mosaic Immunoengineering Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mosaic Immunoengineerin's current stock value. Our valuation model uses many indicators to compare Mosaic Immunoengineerin value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mosaic Immunoengineerin competition to find correlations between indicators driving Mosaic Immunoengineerin's intrinsic value. More Info.Mosaic Immunoengineering is number one stock in return on asset category among its peers. It also is the top company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mosaic Immunoengineerin's earnings, one of the primary drivers of an investment's value.About Mosaic Immunoengineerin Financial Statements
Mosaic Immunoengineerin investors use historical fundamental indicators, such as Mosaic Immunoengineerin's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mosaic Immunoengineerin. Please read more on our technical analysis and fundamental analysis pages.
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. The company was founded in 2020 and is based in Novato, California. Mosaic Immunoengineerin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mosaic OTC Stock Analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.